---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-013829"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2021-07-14T23:59:59+00:00"
generated_at: "2026-06-30T05:26:20.745738+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Bioventus elects Mary Kay Ladone to Board as Class II director effective July 15, 2021

## Summary
- Mary Kay Ladone appointed to Board, Audit and Risk Committee, and Compensation Committee.
- Ladone is SVP, Corporate Development, Strategy and IR at Hill-Rom, with prior roles at Baxalta and Baxter.
- Annual cash retainer $55,000 plus $10,000 for Audit and $7,500 for Compensation Committee service.
- Initial restricted stock unit award with aggregate fair value of $152,000, pro-rated per policy.

## SEC filing metadata
- accession: 0001628280-21-013829
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2021-07-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000162828021013829/0001628280-21-013829-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000162828021013829/bvs-20210714.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-013829
- JSON: https://secwatch.observer/filing/0001628280-21-013829.json
- Plain text: https://secwatch.observer/filing/0001628280-21-013829.txt

## Key facts
- Executive change
  Mary Kay Ladone was elected as Class II Director at Bioventus Inc..
  - Action: elected
  - Role: Class II Director
  source text: On July 12, 2021, the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”) elected Mary Kay Ladone to the Board as a Class II director for a term ending at the 2023 annual meeting of stockholders of the Company, effective July 15, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000162828021013829/0001628280-21-013829-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.